{"eventGroups":[{"deathsNumAffected":45,"deathsNumAtRisk":49,"description":"Intravenous busulfan (Busulfan®) in combination with fludarabine\n\nBusulfan: Daily intravenous dosing to target AVC\n\nFludarabine: Fludarabine dosing will be based on actual body weight. Fludarabine will be infused over 30 minutes before busulfan treatment dose.\n\nCampath: All patients will receive premedication for Campath (daily doses of 20 mg are repeated for up to five times).\n\nStem Cell Transplant: Infusion of bone marrow and donors(related/ unrelated).","id":"EG000","otherNumAffected":1,"otherNumAtRisk":49,"seriousNumAffected":1,"seriousNumAtRisk":49,"title":"Busulfan and Fludarabine"}],"frequencyThreshold":"0","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":49,"numEvents":1}],"term":"Mental Status change"}],"seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":49,"numEvents":1}],"term":"Sepsis"}],"timeFrame":"10 years"}